Search - tctmd.com

Displaying 501 - 520 of 807

Sort: Relevancy | Date

Presentation Aortovascular 2015

Transfemoral TAVR: Current indications and results

Presenter: Susheel K. Kodali

September 19, 2015

Presentation

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Presenter: Johan Bosmans

July 14, 2015

Presentation

Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of IMS III

Presenter: Alex Abou-Chebl

July 14, 2015

Presentation

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Presenter: Sanjit S. Jolly

July 13, 2015

Presentation

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

Presenter: Paolo Scacciatella

July 07, 2015

Presentation

PFO Closure Following Cryptogenic Stroke or TIA

Presenter: Mikaeil Mirzaali

July 02, 2015

Presentation

Endovascular Therapy for Acute Ischemic Stroke

Presenter: Partha Sardar

June 22, 2015

Presentation

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Presenter: David R. Holmes Jr

June 16, 2015

Presentation TVT 2015

Cerebral Protection Devices Are Still Meaningful and Necessary

Presenter: Eberhard Grube

June 05, 2015

Presentation TVT 2015

CTA Is the Gold Standard for TAVR Valve Sizing

Presenter: Jonathon A. Leipsic

June 05, 2015

Presentation TVT 2015

Angiography Is Adequate for Valve Sizing Decisions and PVR Assessment

Presenter: Albert Markus Kasel

June 05, 2015

Presentation TVT 2015

PVR After TAVR Controversies: Clinical Relevance, Diagnostic Considerations, and Postdilation Strategies

Presenter: Susheel K. Kodali

June 05, 2015

Presentation TVT 2015

Defending Selective TEE: The Oh My God Scenarios

Presenter: Rebecca T. Hahn

June 05, 2015

Presentation TVT 2015

The Minimalist Approach = My Standard Practice

Presenter: Ganesh Manoharan

June 05, 2015

Presentation TVT 2015

Strokes After TAVR: Reasons for Declining Frequency

Presenter: Samir R. Kapadia

June 05, 2015

Presentation

Thrombectomy Within 8 Hours After Symptom Onset in Ischemic Stroke

Presenter: T.G. Jovin

April 28, 2015

Presentation ECHO 2015

Transesophageal Echocardiography For Clinical Decision Making In Stroke and Atrial Fibrillation

Presenter: Fletcher A. Miller

April 26, 2015

Presentation

Trends in Endovascular Therapy and Clinical Outcomes

Presenter: Bijoy K. Menon

February 24, 2015

Presentation

Time to Reperfusion and Effect of Intraarterial Treatment in the MR CLEAN Trial

Presenter: P.A. Fransen

February 16, 2015

Presentation

Impact of General Anesthesia on Treatment Effect in the MR CLEAN Trial

Presenter: Olvert A. Berkhemer

February 16, 2015

Advertisement

Transfemoral TAVR: Current indications and results

Incidence and Predictors of Early and Midterm Clinically Relevant Neurological Events After TAVR

Impact of General Anesthesia on Safety and Outcomes in the Endovascular Arm of IMS III

Stroke in the TOTAL Trial: A Randomized Trial of Routine Thrombectomy vs PCI Alone in STEMI

Recurrent Cerebral Ischemia After PFO Closure in Older Patients

PFO Closure Following Cryptogenic Stroke or TIA

Endovascular Therapy for Acute Ischemic Stroke

Meta-analysis: LAA Closure as an Alternative to Warfarin for Stroke Prevention in A-fib

Cerebral Protection Devices Are Still Meaningful and Necessary

CTA Is the Gold Standard for TAVR Valve Sizing

Angiography Is Adequate for Valve Sizing Decisions and PVR Assessment

PVR After TAVR Controversies: Clinical Relevance, Diagnostic Considerations, and Postdilation Strategies

Defending Selective TEE: The Oh My God Scenarios

The Minimalist Approach = My Standard Practice

Strokes After TAVR: Reasons for Declining Frequency

Thrombectomy Within 8 Hours After Symptom Onset in Ischemic Stroke

Transesophageal Echocardiography For Clinical Decision Making In Stroke and Atrial Fibrillation

Trends in Endovascular Therapy and Clinical Outcomes

Time to Reperfusion and Effect of Intraarterial Treatment in the MR CLEAN Trial

Impact of General Anesthesia on Treatment Effect in the MR CLEAN Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content